Drug discovery

Catapult open for business with £1m investment in cutting-edge lab capacity to support UK drug discovery

The BioPontis Alliance hopes its new model for bringing patients’ insights and industry expertise to bear in preclinical research will reduce risk and promote development of rare disease therapies. The Alliance has funding from a Belgian charity for its first project

Shortcomings in the framework for clinical trials, little knowledge of intellectual property law and an awkward relationship between scientists and technology transfer offices are holding back science-industry collaboration, but work is in hand to change things

The League of European Research Universities has once again hit out at IP rules and funding levels in the EU’s Innovative Medicines Initiative, saying academics will be discouraged from taking part in the €2B collaborative research programme

The Drug Discovery Unit at Dundee is to spearhead the development of a national network to allow researchers to work together in fragment-based drug design